2 results
Approved WMORecruiting
To assess the effects and the cost effectiveness of self monitoring of glucose in DM2 patients who are not using insulin on diabetes related distress, glycaemic control and changes in behavioural determinants.
Approved WMOCompleted
Primary: To estimate the MTD or RDE and preferred dosing schedule of LJM716 when administered in combination with trastuzumab in patients with HER2 overexpressing metastatic breast cancer or gastric cancer.Secondary: Safety and tolerability, PK, PD…